CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$2.39
-0.07 (-2.85%)
As of Mar 22, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
198.52M
Net Income
-12,774,022
Gross Margin
42.8%
Profit Margin
-6.4%
Rev Growth
+16.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.8% 42.8% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 198.52M 169.90M 608.59M 622.30M
Gross Profit 84.98M 72.74M 334.31M 341.84M
Operating Income -23,563,921 -18,150,914 88.72M 91.23M
Net Income -12,774,022 -9,839,626 77.66M 87.35M
Gross Margin 42.8% 42.8% 54.9% 54.9%
Operating Margin -11.9% -10.7% 14.6% 14.7%
Profit Margin -6.4% -6.1% 12.8% 14.0%
Rev Growth +16.8% +16.8% +15.9% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 544.31M 499.08M
Total Equity 682.78M 653.80M
D/E Ratio 0.80 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -35,102,597 -28,541,139 120.12M 125.66M
Free Cash Flow 67.66M 69.93M